NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
Back to search
Official data from USPTO
PATIENTS CAN'T WAIT. NEITHER CAN WE.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PATIENTS CAN'T WAIT. NEITHER CAN WE.
ST13
US500000090066400Class
42, 44
Filing
90066400
Registration
7429611
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/25/2024
Trademark type
Word
Nice classes
42, 44
Filing date
07/22/2020
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-09-00
First use in commerce
2023-09-00
Drawing code
4
Owner type
03
Owner location
PRINCETON, NJ
Examiner
SCHLEGELMILCH, JONATHON
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LABCORP DRUG DEVELOPMENT INC.
Covance, Inc.
Representatives
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformaticsbiomarkersgenomicsproteomicsgenotypinggenetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; computer hardware and software design; design and development of software for use in conducting biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; data mining; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug developmentselecting biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug developmentselecting biomarkers for use in testing drugs; lead candidate drug optimization servicesscientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistrypharmaceuticals and clinical trials; acting as an application service provider featuring software for use in database and record management in the fields of medical testingtesting for forensic purposestesting for quality control purposesgenetic testingclinical and analytical testingdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; providing non-downloadable software through a web-based portal to collectorganizereport medical informationmedical recordsdiagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposestesting for forensic research purposestesting for quality control purposesgenetic testing for scientific research purposesmedical and scientific research in the field ofdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; providing temporary use of online non-downloadable software for storingretrievingaccessingdisplayingmanaginganalyzingreviewing information and data in the fields of medical testingtesting for forensic purposestesting for quality control purposesgenetic testingclinical and analytical testingdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; electronic storage of data; consulting services in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control purposes
Class 44
Medical services in the fields of pathologypharmacologyimmunology; medical and psychological counseling; medical testing for diagnostictreatmentscreening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical care and healthcare; medical consulting in the field of patient management and outcomes; providing an online computer database in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical carehealthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical carehealthcare; providing a website featuring medical information in the field of patient management and outcomes
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/23/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/23/2024
DOCK
ASSIGNED TO EXAMINER
05/16/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/22/2024
IUAF
USE AMENDMENT FILED
02/15/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/15/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/25/2023
EX5G
SOU EXTENSION 5 GRANTED
08/24/2023
EXT5
SOU EXTENSION 5 FILED
08/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/15/2023
NOAC
CORRECTED NOA E-MAILED
06/24/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/31/2023
EX4G
SOU EXTENSION 4 GRANTED
05/30/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
05/30/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/13/2023
EXT4
SOU EXTENSION 4 FILED
02/16/2023
DRRR
DIVISIONAL REQUEST RECEIVED
02/16/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/16/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/16/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/17/2022
EX3G
SOU EXTENSION 3 GRANTED
08/15/2022
EXT3
SOU EXTENSION 3 FILED
08/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/18/2022
EX2G
SOU EXTENSION 2 GRANTED
02/16/2022
EXT2
SOU EXTENSION 2 FILED
02/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/18/2021
EX1G
SOU EXTENSION 1 GRANTED
08/16/2021
EXT1
SOU EXTENSION 1 FILED
08/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/16/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2020
PUBO
PUBLISHED FOR OPPOSITION
12/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2020
DOCK
ASSIGNED TO EXAMINER
11/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2020
NWAP
NEW APPLICATION ENTERED
07/25/2020
Continuous trademark protection
Get notified about every new filing that threatens PATIENTS CAN'T WAIT. NEITHER CAN WE. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.